A new phenolic compound, 6-(2-acetyl-3,5-dihydroxybenzyl)-4-hydroxy-3-methyl-2H-pyran-2-one(1), along with other six known phenolic derivatives(2-7), were isolated from the mangrove rhizosphere fungus Penicillium jant...A new phenolic compound, 6-(2-acetyl-3,5-dihydroxybenzyl)-4-hydroxy-3-methyl-2H-pyran-2-one(1), along with other six known phenolic derivatives(2-7), were isolated from the mangrove rhizosphere fungus Penicillium janthinellum HK1-6 cultured in potato dextrose broth medium containing 30 g L^(-1) of natural sea salt. The structure of the new compound(1) was elucidated by comprehensive analysis of spectroscopic data including 1D and 2D NMR spectra. The proposed biosynthetic pathway of compound 1 was also studied in this research. Interestingly, a brominated phenolic derivative, aryl bromide(compound 8), was obtained from this fungal strain cultured in medium containing 30 g L^-1 of NaBr instead of natural sea salt. Compound 8 is proposed as a new natural product and formed through bromination of compound 7 when the fungus was cultured with NaBr. The neuroprotective effect of compound 1 on oxygen-glucose deprivation(OGD)-induced injury was investigated in rat spinal cord astrocytes. MTT assay demonstrated that compound 1 can attenuate OGD-induced cell viability loss in rat spinal cord astrocytes.展开更多
对分离到的一株高抗Cu(200 mm ol/L CuSO4.5H2O)的P en icillium janth inellum菌株GXCR(中国微生物菌种保藏管理委员会普通微生物中心保藏号:CGM CC 1027)进行紫外诱变,获得了3株Cu抗性下降突变体,进一步测定结果表明,3个突变体对A l[A...对分离到的一株高抗Cu(200 mm ol/L CuSO4.5H2O)的P en icillium janth inellum菌株GXCR(中国微生物菌种保藏管理委员会普通微生物中心保藏号:CGM CC 1027)进行紫外诱变,获得了3株Cu抗性下降突变体,进一步测定结果表明,3个突变体对A l[A l2(SO4)3]和Zn(ZnSO4.7H2O)的抗性也显著下降;只有在含Cu的PDA上生长的菌体表面能够形成CuSO4.5H2O样的蓝色晶体。进一步的X-ray衍射的原子微量分析表明,这种蓝色晶体含Cu2+,说明该菌具有Cu的生物矿化作用。菌体表面积累的Cu2+的量与菌株的抗Cu水平有正相关性,说明该菌对Cu的抗性很可能与Cu矿化作用有关。展开更多
Bacterial biofilms are the bacterial aggregates that are embedded in the self-produced matrix of extracellular polymeric substances (EPS) that cause persistent bacterial infections posing significant medical challenge...Bacterial biofilms are the bacterial aggregates that are embedded in the self-produced matrix of extracellular polymeric substances (EPS) that cause persistent bacterial infections posing significant medical challenges. They are recalcitrant to antibiotics and host defenses which make the treatments difficult and costly. Penicillium janthinellum mutant EU2D-21 was found to produce extracellular enzyme complex (amylase, cellulase, protease) under submerged fermentation. Maximum specific enzyme activities were found to be 3.04 IU/mg, 2.61 IU/mg and 3.39 IU/mg for alpha-amylase, cellulase and protease respectively, after 8 days of incubation at 30?C. We evaluated the enzyme complex for its ability to target and degrade the biofilms of different bacteria. We found that it degraded biofilms of Escherichia coli (85.5%), Salmonella enterica (79.72%), Pseudomonas aeruginosa (88.76%) and Staphyloccus aureus (87.42%) within 1 h of incubation at 50?C. The scanning electron microscopy (SEM), quantitation of biofilm removal assay and Crystal violet assay demonstrated that the enzyme complex detached the biofilm exo-polysaccharide matrix and bacteria from the cell surface. These results illustrate the feasibility and benefits of using this enzyme complex as anti-biofilm therapeutics to eradicate biofilms. This can also be used as a promising strategy to improve treatment of multidrug resistant bacterial infections.展开更多
基金supported by the National Natural Science Foundation of China (Nos.81703411, 41830535, U1606403)the Marine S&T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology (Qingdao) (No.2018SD KJ0406-5)+3 种基金the National Science and Technology Major Project for Significant New Drugs Development (No.2018 ZX09735-004)the Program of Open Studio for Druggability Research of Marine Natural Productthe Pilot National Laboratory for Marine Science and Technology (Qingdao, China)Taishan Scholars Program, China。
文摘A new phenolic compound, 6-(2-acetyl-3,5-dihydroxybenzyl)-4-hydroxy-3-methyl-2H-pyran-2-one(1), along with other six known phenolic derivatives(2-7), were isolated from the mangrove rhizosphere fungus Penicillium janthinellum HK1-6 cultured in potato dextrose broth medium containing 30 g L^(-1) of natural sea salt. The structure of the new compound(1) was elucidated by comprehensive analysis of spectroscopic data including 1D and 2D NMR spectra. The proposed biosynthetic pathway of compound 1 was also studied in this research. Interestingly, a brominated phenolic derivative, aryl bromide(compound 8), was obtained from this fungal strain cultured in medium containing 30 g L^-1 of NaBr instead of natural sea salt. Compound 8 is proposed as a new natural product and formed through bromination of compound 7 when the fungus was cultured with NaBr. The neuroprotective effect of compound 1 on oxygen-glucose deprivation(OGD)-induced injury was investigated in rat spinal cord astrocytes. MTT assay demonstrated that compound 1 can attenuate OGD-induced cell viability loss in rat spinal cord astrocytes.
文摘对分离到的一株高抗Cu(200 mm ol/L CuSO4.5H2O)的P en icillium janth inellum菌株GXCR(中国微生物菌种保藏管理委员会普通微生物中心保藏号:CGM CC 1027)进行紫外诱变,获得了3株Cu抗性下降突变体,进一步测定结果表明,3个突变体对A l[A l2(SO4)3]和Zn(ZnSO4.7H2O)的抗性也显著下降;只有在含Cu的PDA上生长的菌体表面能够形成CuSO4.5H2O样的蓝色晶体。进一步的X-ray衍射的原子微量分析表明,这种蓝色晶体含Cu2+,说明该菌具有Cu的生物矿化作用。菌体表面积累的Cu2+的量与菌株的抗Cu水平有正相关性,说明该菌对Cu的抗性很可能与Cu矿化作用有关。
文摘Bacterial biofilms are the bacterial aggregates that are embedded in the self-produced matrix of extracellular polymeric substances (EPS) that cause persistent bacterial infections posing significant medical challenges. They are recalcitrant to antibiotics and host defenses which make the treatments difficult and costly. Penicillium janthinellum mutant EU2D-21 was found to produce extracellular enzyme complex (amylase, cellulase, protease) under submerged fermentation. Maximum specific enzyme activities were found to be 3.04 IU/mg, 2.61 IU/mg and 3.39 IU/mg for alpha-amylase, cellulase and protease respectively, after 8 days of incubation at 30?C. We evaluated the enzyme complex for its ability to target and degrade the biofilms of different bacteria. We found that it degraded biofilms of Escherichia coli (85.5%), Salmonella enterica (79.72%), Pseudomonas aeruginosa (88.76%) and Staphyloccus aureus (87.42%) within 1 h of incubation at 50?C. The scanning electron microscopy (SEM), quantitation of biofilm removal assay and Crystal violet assay demonstrated that the enzyme complex detached the biofilm exo-polysaccharide matrix and bacteria from the cell surface. These results illustrate the feasibility and benefits of using this enzyme complex as anti-biofilm therapeutics to eradicate biofilms. This can also be used as a promising strategy to improve treatment of multidrug resistant bacterial infections.
